as on November 15, 2025 at 2:29 am IST
Day's Low
Day's High
1.31%
Downside
1.60%
Upside
52 Week's Low
52 Week's High
22.42%
Downside
113.83%
Upside
Check Niagen Bioscience Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$836.5M
EPS (TTM)
0.1233
Dividend Yield
0.00%
PE Ratio (TTM)
59
Industry PE ratio
0PEG Ratio
0Return On Equity TTM
33.47%
Track how Niagen Bioscience Inc P/E has moved over time to understand its valuation trends.
Niagen Bioscience Inc in the last 5 years
Lowest (71.45x)
June 30, 2025
Industry (0.00x)
November 14, 2025
Today (59.00x)
November 14, 2025
Highest (77.34x)
March 31, 2025
Today’s Price to Earnings Ratio: 59.00x
Compare market cap, revenue, PE, and other key metrics of Niagen Bioscience Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $836.5M | NA | 59 | 13.07% | |
| BUY | $59.8B | 235.01% | 1414.81 | 1.36% | |
| NA | $40.9B | NA | 712.21 | 1.38% | |
| BUY | $110.2B | 92.67% | 30.58 | 31.35% | |
| BUY | $71.6B | 22.7% | 16.34 | 32.13% |
Search interest for Niagen Bioscience Inc Stock has decreased by -59% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 9 quarters, 19.49M → 33.98M (in $), with an average increase of 6.6% per quarter
Best in 3 Years
![]()
In the last 3 years, NAGE has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 3 years, NAGE stock has moved up by 290.3%
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 3.60M → 4.57M (in $), with an average increase of 21.2% per quarter
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 93.3% return, outperforming this stock by 92.6%
| Organisation | Niagen Bioscience Inc |
| Headquarters | 10900 Wilshire Blvd, Los Angeles, CA, United States, 90024 |
| CEO | Mr. Robert N. Fried |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Ozan Pamir C.F.A. | CFO & Principal Accounting Officer |
Mr. Carlos Lopez | Senior VP & General Counsel |
Mr. James Lee | Controller |
Dr. Andrew Shao Ph.D. | Senior Vice President of Global Regulatory & Scientific Affairs |
Ms. Michiko Kelley | Chief Marketing Officer |
Kendall Knysch | Head of Media Relations & Partnerships |
Mr. Frank Louis Jaksch Jr. | Co-Founder & Chairman |
Ms. Chu Yan | Managing Director of Asia Pacific |
Wesley Yu | Vice President of Finance |
Mr. Robert N. Fried | CEO & Director |
Niagen Bioscience Inc share price today is $6.87 as on at the close of the market. Niagen Bioscience Inc share today touched a day high of $6.98 and a low of $6.78.
Niagen Bioscience Inc share touched a 52 week high of $14.69 on and a 52 week low of $5.33 on . Niagen Bioscience Inc stock price today i.e. is closed at $6.87,which is 53.23% down from its 52 week high and 28.89% up from its 52 week low.
Niagen Bioscience Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Niagen Bioscience Inc (NAGE) shares with as little as ₹88.74 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.40 in Niagen Bioscience Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Niagen Bioscience Inc share’s latest price of $6.87 as on November 15, 2025 at 2:29 am IST, you will get 1.4556 shares of Niagen Bioscience Inc. Learn more about
fractional shares .